1997
DOI: 10.1016/s0960-9822(06)00123-0
|View full text |Cite
|
Sign up to set email alerts
|

The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function

Abstract: Our observations indicate that Smad4 cooperates with Smad1, Smad2 and Smad3 to act as a common mediator of signaling by TGF-beta-related factors, and provide a mechanism that explains the dominant-negative interference with receptor signaling that results from expression of the naturally occurring Smad4/DPC 4 truncation mutant.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

10
213
1
3

Year Published

1997
1997
2007
2007

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 291 publications
(227 citation statements)
references
References 21 publications
10
213
1
3
Order By: Relevance
“…Co-transfection of Cited2 was able to enhance TGF-bmediated expression of wild-type but not MMP9 promoter mutated at the AP-1 site (Figure 6b). Smad7 and dominant negative Smad4 have been shown to inhibit Smad pathway by interfering with phosphorylation and translocation of endogenous Smads, respectively (Hayashi et al, 1997;Zhang et al, 1997). Coexpression of Smad7 or dominant negative Smad4 attenuated Cited2-mediated expression of MMP9 promoter reporter, suggesting that endogenous Smads are required for functional interaction with Cited2 to enhance MMP9 expression (Figure 6b).…”
Section: Cited2 Enhances Tgf-b-mediated Mmp9 Promoter Reporter Activitymentioning
confidence: 99%
“…Co-transfection of Cited2 was able to enhance TGF-bmediated expression of wild-type but not MMP9 promoter mutated at the AP-1 site (Figure 6b). Smad7 and dominant negative Smad4 have been shown to inhibit Smad pathway by interfering with phosphorylation and translocation of endogenous Smads, respectively (Hayashi et al, 1997;Zhang et al, 1997). Coexpression of Smad7 or dominant negative Smad4 attenuated Cited2-mediated expression of MMP9 promoter reporter, suggesting that endogenous Smads are required for functional interaction with Cited2 to enhance MMP9 expression (Figure 6b).…”
Section: Cited2 Enhances Tgf-b-mediated Mmp9 Promoter Reporter Activitymentioning
confidence: 99%
“…TGF-␤, Smad2 and Smad4 translocate to the nuclei (12,20,23,28,29,33). To investigate whether phosphorylation of Ser 465 and Ser 467 in Smad2 is important for TGF-␤-dependent nuclear translocation of the Smad proteins, we used Mv1Lu cells stably transfected with wild-type Smad2 or its mutants.…”
Section: Smad2 Phosphorylation and Interaction With Smad4mentioning
confidence: 99%
“…Smad4 is a common component of TGF-␤, activin, and BMP signaling (32)(33)(34). Smad4 phosphorylation has thus far been reported only after activin stimulation of transfected cells (32).…”
mentioning
confidence: 99%
“…BMPs bind to serine-threonine kinases type I receptors (BMPRIA) and type II receptors (BMPRII) [14] that induce phosphorylation of intracellular SMADs 1, 5, or 8 at their carboxy terminus, at serine 463/465 [15]. The activated SMADs then bind to SMAD4, translocate to the nucleus, and in conjunction with specific DNA factors, activate or repress gene transcription [16]. SMAD1 can also be phosphorylated at its mid-protein linker region by activated Erk kinase (downstream of RAS), slowing or inhibiting nuclear accumulation of BMP-activated SMAD1 in mouse mammary cells [17,18].…”
Section: Introductionmentioning
confidence: 99%